3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Surgical Wound Infection
2
Skin Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Fistula
1
Leukemia, Myeloid, Acute
1
Intestinal Neoplasms
1
Duodenal Neoplasms
1
Diarrhea
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Standard of Care
18
Gemcitabine
18
Radiosurgery
14
Drug Therapy
13
Blood Specimen Collection
13
Endoscopic Ultrasound-Guided Fine Needle Aspiration
11
Exercise
10
Pancreaticoduodenectomy
9
Practice Guidelines as Topic
8
Methods
8
Magnetic Resonance Spectroscopy
8
Biopsy, Fine-Needle
8
Capecitabine
7
Early Intervention, Educational
6
Biopsy
6
Surveys and Questionnaires
5
Stents
5
Specimen Handling
5
Resistance Training
5
Radiofrequency Ablation
5
Psychiatric Rehabilitation
5
Oxaliplatin
5
Fluorouracil
5
Cholangiopancreatography, Endoscopic Retrograde
5
130-nm albumin-bound paclitaxel
5
Secretin
4
Radiotherapy
4
Irinotecan
4
Heavy Ion Radiotherapy
4
Electroporation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pancreatic Neoplasms
×
Anti-Bacterial Agents
×
Clear all
NCT03631173
2026-04-28
MINIMUM
Oslo University Hospital
Phase NA
Active not recruiting
201 enrolled